1. Home
  2. PRTC vs BYND Comparison

PRTC vs BYND Comparison

Compare PRTC & BYND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRTC
  • BYND
  • Stock Information
  • Founded
  • PRTC 2015
  • BYND 2009
  • Country
  • PRTC United States
  • BYND United States
  • Employees
  • PRTC 90
  • BYND N/A
  • Industry
  • PRTC Biotechnology: Pharmaceutical Preparations
  • BYND Packaged Foods
  • Sector
  • PRTC Health Care
  • BYND Consumer Staples
  • Exchange
  • PRTC Nasdaq
  • BYND Nasdaq
  • Market Cap
  • PRTC 504.9M
  • BYND 416.9M
  • IPO Year
  • PRTC N/A
  • BYND 2019
  • Fundamental
  • Price
  • PRTC $20.80
  • BYND $5.84
  • Analyst Decision
  • PRTC Buy
  • BYND Sell
  • Analyst Count
  • PRTC 1
  • BYND 6
  • Target Price
  • PRTC $45.00
  • BYND $5.50
  • AVG Volume (30 Days)
  • PRTC 3.4K
  • BYND 2.1M
  • Earning Date
  • PRTC 08-28-2024
  • BYND 11-06-2024
  • Dividend Yield
  • PRTC N/A
  • BYND N/A
  • EPS Growth
  • PRTC N/A
  • BYND N/A
  • EPS
  • PRTC N/A
  • BYND N/A
  • Revenue
  • PRTC $468,000.00
  • BYND $323,473,000.00
  • Revenue This Year
  • PRTC N/A
  • BYND N/A
  • Revenue Next Year
  • PRTC $139.60
  • BYND $3.05
  • P/E Ratio
  • PRTC N/A
  • BYND N/A
  • Revenue Growth
  • PRTC N/A
  • BYND N/A
  • 52 Week Low
  • PRTC $17.08
  • BYND $5.13
  • 52 Week High
  • PRTC $34.00
  • BYND $12.12
  • Technical
  • Relative Strength Index (RSI)
  • PRTC 55.95
  • BYND 40.83
  • Support Level
  • PRTC $20.35
  • BYND $5.88
  • Resistance Level
  • PRTC $20.95
  • BYND $6.60
  • Average True Range (ATR)
  • PRTC 0.62
  • BYND 0.32
  • MACD
  • PRTC 0.10
  • BYND -0.03
  • Stochastic Oscillator
  • PRTC 75.51
  • BYND 1.24

About PRTC PureTech Health plc

PureTech Health PLC is a biopharma company developing medicines to modulate the adaptive human system. It is a cross-disciplinary healthcare company developing products that could improve the lives of patients. The company is focused on developing and commercializing highly differentiated medicines for devastating diseases, including inflammatory, fibrotic, and immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, and neurological & neuropsychological disorders, among others. It operates in the following segments: Wholly-Owned Programs, Controlled Founded Entities, and Parent Companies & Others. The company has a robust pipeline of advanced programs that are post-human proof of concept and focused on some of society's healthcare needs.

About BYND Beyond Meat Inc.

Beyond Meat Inc is a provider of plant-based meat company offering a portfolio of revolutionary plant-based meats. It builds meat directly from plants, an innovation that enables consumers to experience the taste, texture and other sensory attributes of popular animal-based meat products while enjoying the nutritional and environmental benefits of eating plant-based meat product It has products such as burgers, sausage, ground beef, jerky, meatballs and chicken. The company generates revenue from sales of its products to the customers across mainstream grocery, mass merchandiser, club store, convenience store and natural retailer channels, and various food-away-from-home channels, including restaurants, foodservice outlets and schools, mainly in the United States.

Share on Social Networks: